Literature DB >> 23647577

Mortality from sudden unexpected death in epilepsy (SUDEP) in a cohort of adults with intellectual disability.

R Kiani1, F Tyrer, A Jesu, S Bhaumik, S Gangavati, G Walker, S Kazmi, M Barrett.   

Abstract

BACKGROUND: People with intellectual disability (ID) and epilepsy are more likely to die prematurely than the general population. A significant number of deaths in people with epilepsy may be potentially preventable through better seizure control, regular monitoring and raising awareness among patients and carers. The aim of this project was to study mortality from sudden unexpected death in epilepsy (SUDEP) in adults with ID.
METHODS: All adults (≥20 years old) living in Leicester city, Leicestershire and Rutland, UK, with ID between 1993 and 2010 were identified using the Leicestershire Intellectual Disability Register database. People with and without ID who died during the same period were identified using death certificate data from the Office for National Statistics (ONS). Deaths from probable and definite SUDEP were identified. Additional information on adults with ID who had died from probable or definite SUDEP was obtained from case notes and post-mortem reports, where available. Cases of probable and definite SUDEP in adults with ID were compared with the general population using standardised mortality ratios (SMRs).
RESULTS: A total of 898 adults with ID had died over the 18-year study period. Of these, 244 deaths (27%) occurred in people with ID who had a diagnosis of epilepsy. Twenty-six people with ID died from probable or definite SUDEP, which was the second most common cause of death among adults with ID and epilepsy. All-cause specific SMRs were 2.2 [95% confidence interval (CI): 2.0-2.4] and 2.8 (95% CI: 2.5-3.1) for men and women with ID respectively. SMRs were 3.2 (95% CI: 2.7-3.8) and 5.6 (95% CI: 4.6-6.7) for men and women with epilepsy and ID respectively. During the same study period, 83 adults without ID had died of probable or definite SUDEP. The SMRs for SUDEP in patients with ID were 37.6 for men (95% CI: 21.9-60.2) and 52.0 for women (95% CI: 23.8-98.8). We found that in the majority of ID cases there was little detailed documentation on the circumstances surrounding deaths, no communication with patients/carers about risk of SUDEP and an absence of post-mortem reports or carers' referral for bereavement counselling.
CONCLUSION: The authors believe that a comprehensive risk management under a multiagency/multidisciplinary framework should be undertaken for all adults with ID and epilepsy in day-to-day clinical practice to reduce mortality in people with ID.
© 2013 MENCAP and International Association of the Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd.

Entities:  

Keywords:  SUDEP; death certificate; epilepsy; intellectual disability; standardised mortality ratio; sudden unexpected death in epilepsy

Mesh:

Year:  2013        PMID: 23647577     DOI: 10.1111/jir.12047

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  4 in total

Review 1.  Medication use and potentially inappropriate prescribing in older adults with intellectual disabilities: a neglected area of research.

Authors:  Maire O'Dwyer; Philip McCallion; Mary McCarron; Martin Henman
Journal:  Ther Adv Drug Saf       Date:  2018-06-20

2.  Mortality Among Adults With Intellectual Disability in England: Comparisons With the General Population.

Authors:  Fay J Hosking; Iain M Carey; Sunil M Shah; Tess Harris; Stephen DeWilde; Carole Beighton; Derek G Cook
Journal:  Am J Public Health       Date:  2016-06-16       Impact factor: 9.308

Review 3.  A review of the causes and risk factors for sudden unexpected death in the young.

Authors:  Yuvika Vandayar; Laura Jane Heathfield
Journal:  Forensic Sci Med Pathol       Date:  2022-02-08       Impact factor: 2.456

4.  Steps to prevent SUDEP: the validity of risk factors in the SUDEP and seizure safety checklist: a case control study.

Authors:  Rohit Shankar; Matthew Walker; Brendan McLean; Richard Laugharne; Fucundo Ferrand; Jane Hanna; Craig Newman
Journal:  J Neurol       Date:  2016-06-22       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.